Latest news with #U.SFoodandDrugAdministration
Yahoo
21-05-2025
- Business
- Yahoo
Ziploc Is Being Sued Over Claims Its Bags Release Harmful Microplastics Into Food
Earlier this year, the U.S Food and Drug Administration (FDA) announced a ban on Red No. 3 in food and drinks, a move many felt was a step in the right direction regarding industry standards. Not long after, however, the FDA announced it would be temporarily halting its milk testing program, a change that drew criticism from food safety experts. Now, as grocery prices continue to rise, consumers are paying more attention than ever to their shopping carts. Recently, a class action lawsuit was filed against Wheat Thins, accusing the brand of misrepresenting its ingredients. Now, a popular storage bag brand is under fire after allegedly failing to disclose the risks of its products. On April 25, 2025, a lawsuit was filed against Ziploc, an S.C. Johnson-owned brand. The lawsuit, filed by Linda Cheslow, alleges that certain Ziploc bags are labeled as 'microwave safe' and suitable for 'freezer' use, giving shoppers the impression they were safe to use in those ways. Cheslow, however, believes the brand is misleading customers and putting them at risk for microplastic consumption. An issue, the plaintiff says, is made worse by Ziploc's claim that its products are reusable. 'These products are made from polyethylene and polypropylene—materials that scientific and medical evidence shows release microplastics when microwaved and frozen—making them fundamentally unfit for microwave and freezer use,' reads page four of the lawsuit document. Polyethylene and polypropylene are two common food-grade plastic materials used in the production of kitchen goods, including cutting boards, storage containers, and cling wrap, to name a few. When exposed to extreme temperatures, such as heat or cold, they have been found to release microplastics, which can leach into food. Microplastics, while invisible to the naked eye, have been linked to a variety of health concerns, including increased cancer risk, immune dysfunction, and inflammation. Cheslow believes that the company is putting families at risk by failing to disclose this information, and it's doing so 'for profit and to gain an unfair competitive edge in the marketplace.' S.C. Johnson has denied these claims, and litigation is ongoing. This is a class action lawsuit, meaning that it was filed on behalf of all who have purchased the product. At this time, there is no action consumers need to take. In the future, you may be able to file a claim and receive a monetary reward if a settlement fund is established. The products in question include, but are not limited to: Ziploc Freezer Bags Pint Ziploc Freezer Bags Quart Freezer Bags Gallon Ziploc Slider Freezer Bags Quart Ziploc Slider Freezer Gallon Ziploc Slider Storage Bags Quart Ziploc Slider Storage Bags Gallon Ziploc Containers Additionally, consumers may find photos of the products beginning on page nine of the lawsuit documents. Be sure to take note of which products are included when you compile your receipts and stay up to date as the case proceeds. Read the original article on ALLRECIPES
CNA
24-04-2025
- Health
- CNA
CNA938 Rewind - U.S FDA to phase out petroleum-based food dyes
CNA938 Rewind The U.S Food and Drug Administration plans to phase out the use of petroleum-based synthetic dyes in the US food supply due to health concerns. The dyes, which give food and drinks brighter colours and make them more appealing, can be found in many candies, cereals, beverages and even in some medications. Andrea Heng and Hairianto Diman look at the viability of this move and how it will impact the sector, with Dr Anneline Padayachee, Scientific consultant of The Food and Nutrition Doctor and Adjunct Senior Lecturer, University of Queensland.
The Hill
04-02-2025
- Health
- The Hill
Sanjay Gupta: New non-opioid pain medication ‘a pretty big deal'
Dr. Sanjay Gupta said Tuesday that the approval of a new non-opioid pain medication is 'a pretty big deal.' 'This is a pretty big deal,' Gupta said. 'As you just mentioned, it's been since 1998 that there's been a new pain medication approved. I mean, the FDA typically approves dozens of medications for all sorts of things, but not pain, so patients really haven't had many options.' The 'The Lead with Jake Tapper' on CNN comments from Gupta follow Journavx (suzetrigine) oral tablets being approved by the U.S Food and Drug Administration (FDA) last week as a first-in-class non-opioid analgesic for the treatment of acute pain in adults. 'Today's approval is an important public health milestone in acute pain management,' said Jacqueline Corrigan-Curay, the FDA's Center for Drug Evaluation and Research acting director, in a previous statement. 'A new non-opioid analgesic therapeutic class for acute pain offers an opportunity to mitigate certain risks associated with using an opioid for pain and provides patients with another treatment option,' she continued. The approval of the medication is innovating due to it providing another option besides opioids. Americans in the tens of millions are prescribed opioids like oxycodone and fentanyl for pain each year. 'I think what is unique about this, if you think about opioids that you just mentioned, they tend to work primarily on the brain,' Gupta said Tuesday. 'The brain processes all pain, so … that's why they're sedating, they can cause problems with addiction.' 'These pain medications, suzetrigine, Journavx as it's called, works sort of more at the location of the pain, sort of trying to block the signals coming from the source of pain, going to the brain. As a result, you shouldn't get euphoria,' he added.
